| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| Seagen Inc. | COM | 81181C104 | $6,028,695,304 | 46,912,266 | SOLE | |||
| Incyte Corporation | COM | 45337C102 | $2,903,967,271 | 36,154,971 | SOLE | |||
| BeiGene, Ltd. | SPONSORED ADR | 07725L102 | $2,566,457,206 | 11,668,897 | SOLE | |||
| BioMarin Pharmaceutical Inc. | COM | 09061G101 | $788,644,924 | 7,620,494 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 4225108 | $667,421,897 | 41,923,486 | SOLE | |||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | $605,136,441 | 4,954,855 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $448,469,048 | 1,545,113 | SOLE | |||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $185,046,185 | 6,354,608 | SOLE | |||
| BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | $145,920,191 | 12,710,818 | SOLE | |||
| Immunocore Holdings plc | ADS | 45258D105 | $143,858,118 | 2,520,731 | SOLE | |||
| Akero Therapeutics, Inc. | COM | 00973Y108 | $129,787,114 | 2,368,378 | SOLE | |||
| Replimune Group, Inc. | COM | 76029N106 | $124,529,216 | 4,578,280 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $123,943,108 | 17,310,490 | SOLE | |||
| Horizon Therapeutics Public Ltd Co | SHS | G46188101 | $110,354,933 | 969,727 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $106,132,634 | 280,159 | SOLE | |||
| AbCellera Biologics Inc. | COM | 00288U106 | $105,860,323 | 10,450,180 | SOLE | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | $71,880,432 | 2,879,825 | SOLE | |||
| Chinook Therapeutics, Inc. | COM | 16961L106 | $66,393,472 | 2,534,102 | SOLE | |||
| Entrada Therapeutics, Inc. | COM | 29384C108 | $65,785,873 | 4,865,819 | SOLE | |||
| Mirati Therapeutics, Inc. | COM | 60468T105 | $63,877,313 | 1,409,784 | SOLE | |||
| Prelude Therapeutics Inc. | COM | 74065P101 | $61,147,897 | 10,123,824 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $58,646,587 | 16,067,558 | SOLE | |||
| Aerovate Therapeutics, Inc. | COM | 8064107 | $57,922,232 | 1,976,868 | SOLE | |||
| IGM Biosciences, Inc. | COM | 449585108 | $53,685,295 | 3,156,102 | SOLE | |||
| Immatics N.V. | SHS | N44445109 | $45,179,476 | 5,187,081 | SOLE | |||
| Nurix Therapeutics, Inc. | COM | 67080M103 | $42,625,733 | 3,882,125 | SOLE | |||
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $41,937,663 | 2,799,577 | SOLE | |||
| SpringWorks Therapeutics, Inc. | COM | 85205L107 | $39,757,273 | 1,528,538 | SOLE | |||
| IDEAYA Biosciences, Inc. | COM | 45166A102 | $30,314,010 | 1,668,355 | SOLE | |||
| Denali Therapeutics Inc. | COM | 24823R105 | $30,277,804 | 1,088,738 | SOLE | |||
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | $29,637,126 | 751,639 | SOLE | |||
| Verve Therapeutics, Inc. | COM | 92539P101 | $27,409,856 | 1,416,530 | SOLE | |||
| DICE Therapeutics, Inc. | COM | 23345J104 | $26,900,858 | 862,207 | SOLE | |||
| Travere Therapeutics, Inc. | COM | 89422G107 | $25,767,113 | 1,225,255 | SOLE | |||
| Bicycle Therapeutics plc | SPONSORED ADS | 88786108 | $24,976,894 | 843,814 | SOLE | |||
| AnaptysBio, Inc. | COM | 32724106 | $24,045,885 | 775,924 | SOLE | |||
| Krystal Biotech, Inc. | COM | 501147102 | $23,981,162 | 302,716 | SOLE | |||
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $22,359,824 | 14,614,264 | SOLE | |||
| FibroGen, Inc. | COM | 31572Q808 | $22,030,880 | 1,375,211 | SOLE | |||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | $21,820,225 | 470,974 | SOLE | |||
| Heron Therapeutics, Inc. | COM | 427746102 | $20,329,195 | 8,131,678 | SOLE | |||
| 2seventy bio, Inc. | COM | 901384107 | $19,327,911 | 2,062,744 | SOLE | |||
| Insmed Incorporated | Note 0.75% 6/1/2028 | 457669AB5 | $19,229,604 | 23,500,000 | SOLE | |||
| Prime Medicine, Inc. | COM | 74168J101 | $19,108,898 | 1,028,466 | SOLE | |||
| Biomea Fusion, Inc. | COM | 09077A106 | $17,741,432 | 2,104,559 | SOLE | |||
| bluebird bio, Inc. | COM | 09609G100 | $17,298,028 | 2,499,715 | SOLE | |||
| ARS Pharmaceuticals, Inc. | COM | 82835W108 | $17,115,027 | 2,006,451 | SOLE | |||
| Invitae Corporation | COM | 46185L103 | $15,627,785 | 8,402,035 | SOLE | |||
| Opthea Limited | SPONSORED ADS | 68386J208 | $14,425,856 | 2,691,391 | SOLE | |||
| Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | $14,353,080 | 9,830,877 | SOLE |